Live Interview: Telomerase gene therapy with Liz Parrish, CEO and Patient Zero

Ed Park, MD age-related-diseases, dr ed park, gene therapy, interview, Telomerase Activation Medicine Leave a Comment


In this light-hearted interview, we chat with BioViva CEO Liz Parrish, who has heroically injected herself with a live virus meant to transfect her with two genes- telomerase and follistatin.

Her personal hope and that of her company is that it will not harm her but lizhulkrather extend her healthy lifespan and allow her to maintain muscle mass despite her age of 45.

Learn about the journey that may lead her to be known as the Marie Curie (or the Dr. Bruce Banner) of our generation.

Will telomerase gene therapy prove to be a cure for aging?  Time will tell.

 

Leave a Reply

Your email address will not be published. Required fields are marked *